Clinical Trials Browser

Phase 2 × Bile Duct Neoplasms × Yttrium-90 × Clear all

NCT05655949 2025-03-10

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma